Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: a prospective cohort study
Tóm tắt
The aim of this study was to examine the associations between 16 specific single nucleotide polymorphisms (SNPs) in 8 obesity-related genes and overall and cause-specific mortality. We also examined the associations between the SNPs and body mass index (BMI) and change in BMI over time. Data were analyzed from 9,919 individuals who participated in two large community-based cohort studies conducted in Washington County, Maryland in 1974 (CLUE I) and 1989 (CLUE II). DNA from blood collected in 1989 was genotyped for 16 SNPs in 8 obesity-related genes: monoamine oxidase A (MAOA), lipoprotein lipase (LPL), paraoxonase 1 and 2 (PON1 and PON2), leptin receptor (LEPR), tumor necrosis factor-α (TNFα), and peroxisome proliferative activated receptor-γ and -δ (PPARG and PPARD). Data on height and weight in 1989 (CLUE II baseline) and at age 21 were collected from participants at the time of blood collection. All participants were followed from 1989 to the date of death or the end of follow-up in 2005. Cox proportional hazards regression was used to obtain the relative risk (RR) estimates and 95% confidence intervals (CI) for each SNP and mortality outcomes. The results showed no patterns of association for the selected SNPs and the all-cause and cause-specific mortality outcomes, although statistically significant associations (p < 0.05) were observed between PPARG rs4684847 and all-cause mortality (CC: reference; CT: RR 0.99, 95% CI 0.89, 1.11; TT: RR 0.60, 95% CI 0.39, 0.93) and cancer-related mortality (CC: reference; CT: RR 1.01, 95% CI 0.82, 1.25; TT: RR 0.22, 95% CI 0.06, 0.90) and TNFα rs1799964 and cancer-related mortality (TT: reference; CT: RR 1.23, 95% CI 1.03, 1.47; CC: RR 0.83, 95% CI 0.54, 1.28). Additional analyses showed significant associations between SNPs in LEPR with BMI (rs1137101) and change in BMI over time (rs1045895 and rs1137101). Findings from this cohort study suggest that the selected SNPs are not associated with overall or cause-specific death, although several LEPR SNPs may be related to BMI and BMI change over time.
Tài liệu tham khảo
Flegal KM, Graubard BI, Williamson DF, Gail MH: Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007, 298: 2028-2037. 10.1001/jama.298.17.2028.
Flegal KM, Graubard BI, Williamson DF, Gail MH: Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005, 293: 1861-1867. 10.1001/jama.293.15.1861.
Calle EE, Teras LR, Thun MJ: Obesity and mortality. N Engl J Med. 2005, 353: 2197-2199. 10.1056/NEJM200511173532020.
Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF: Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006, 355: 763-778. 10.1056/NEJMoa055643.
Katzmarzyk PT, Janssen I, Ardern CI: Physical inactivity, excess adiposity and premature mortality. Obes Rev. 2003, 4: 257-290. 10.1046/j.1467-789X.2003.00120.x.
McGee DL: Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol. 2005, 15: 87-97. 10.1016/j.annepidem.2004.05.012.
Ogden CL, Yanovski SZ, Carroll MD, Flegal KM: The epidemiology of obesity. Gastroenterology. 2007, 132: 2087-2102. 10.1053/j.gastro.2007.03.052.
Spiegelman BM, Hu E, Kim JB, Brun R: PPAR gamma and the control of adipogenesis. Biochimie. 1997, 79: 111-112. 10.1016/S0300-9084(97)81500-3.
Wang H, Eckel RH: Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab. 2009, 297: E271-E288. 10.1152/ajpendo.90920.2008.
Yang R, Barouch LA: Leptin signaling and obesity: cardiovascular consequences. Circ Res. 2007, 101: 545-559. 10.1161/CIRCRESAHA.107.156596.
Camps J, Marsillach J, Joven J: The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci. 2009, 46: 83-106. 10.1080/10408360802610878.
Fuemmeler BF, gurs-Collins TD, McClernon FJ, Kollins SH, Kail ME, Bergen AW, shley-Koch AE: Genes implicated in serotonergic and dopaminergic functioning predict BMI categories. Obesity (Silver Spring). 2008, 16: 348-355. 10.1038/oby.2007.65.
Yang W, Kelly T, He J: Genetic epidemiology of obesity. Epidemiol Rev. 2007, 29: 49-61. 10.1093/epirev/mxm004.
Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, Perusse L, Bouchard C: The human obesity gene map: the 2005 update. Obesity (Silver Spring). 2006, 14: 529-644. 10.1038/oby.2006.71.
Genkinger JM, Platz EA, Hoffman SC, Strickland P, Huang HY, Comstock GW, Helzlsouer KJ: C47T polymorphism in manganese superoxide dismutase (MnSOD), antioxidant intake and survival. Mech Ageing Dev. 2006, 127: 371-377. 10.1016/j.mad.2005.12.006.
Klintschar M, Neuhuber F: Evaluation of an alkaline lysis method for the extraction of DNA from whole blood and forensic stains for STR analysis. J Forensic Sci. 2000, 45: 669-673.
Rubin DB: Inference and missing data. Biometrika. 1976, 63: 581-592. 10.1093/biomet/63.3.581.
Kooperberg C, Ruczinski I, LeBlanc ML, Hsu L: Sequence analysis using logic regression. Genetic Epidemiology. 2001, 21: S626-S631.
Ruczinski I, Kooperberg C, LeBlanc ML: Logic regression. Journal of Computational and Graphical Statistics. 2003, 12: 475-511. 10.1198/1061860032238.
Gallicchio L, Chang H, Christo DK, Thuita L, Huang HY, Strickland P, Ruczinski I, Hoffman SC, Helzlsouer KJ: Single nucleotide polymorphisms in inflammation-related genes and mortality in a community-based cohort in Washington County, Maryland. Am J Epidemiol. 2008, 167: 807-813. 10.1093/aje/kwm378.
Rea IM, McKeown PP, McMaster D, Young IS, Patterson C, Savage MJ, Belton C, Marchegiani F, Olivieri F, Bonafe M, et al: Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis. Exp Gerontol. 2004, 39: 629-635. 10.1016/j.exger.2003.11.019.
Bonafe M, Marchegiani F, Cardelli M, Olivieri F, Cavallone L, Giovagnetti S, Pieri C, Marra M, Antonicelli R, Troiano L, et al: Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians. Eur J Hum Genet. 2002, 10: 292-296. 10.1038/sj.ejhg.5200806.
Marchegiani F, Marra M, Spazzafumo L, James RW, Boemi M, Olivieri F, Cardelli M, Cavallone L, Bonfigli AR, Franceschi C: Paraoxonase activity and genotype predispose to successful aging. J Gerontol A Biol Sci Med Sci. 2006, 61: 541-546.
Christiansen L, Bathum L, Frederiksen H, Christensen K: Paraoxonase 1 polymorphisms and survival. Eur J Hum Genet. 2004, 12: 843-847. 10.1038/sj.ejhg.5201235.
Novelli V, Viviani AC, Roncarati R, Guffanti G, Malovini A, Piluso G, Puca AA: Lack of replication of genetic associations with human longevity. Biogerontology. 2008, 9: 85-92. 10.1007/s10522-007-9116-4.
Heijmans BT, Westendorp RG, Slagboom PE: Common gene variants, mortality and extreme longevity in humans. Exp Gerontol. 2000, 35: 865-877. 10.1016/S0531-5565(00)00171-6.
Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN: Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett. 1998, 423: 57-60. 10.1016/S0014-5793(98)00064-7.
Cardon LR, Palmer LJ: Population stratification and spurious allelic association. Lancet. 2003, 361: 598-604. 10.1016/S0140-6736(03)12520-2.
Paracchini V, Pedotti P, Taioli E: Genetics of leptin and obesity: a HuGE review. Am J Epidemiol. 2005, 162: 101-114. 10.1093/aje/kwi174.
Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM, et al: Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007, 316: 1336-1341. 10.1126/science.1142364.
Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM, Berndt SI, Elliott AL, Jackson AU, Lamina C, et al: Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009, 41: 25-34. 10.1038/ng.287.
Meyre D, Delplanque J, Chevre JC, Lecoeur C, Lobbens S, Gallina S, Durand E, Vatin V, Degraeve F, Proenca C, et al: Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet. 2009, 41: 157-159. 10.1038/ng.301.
Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P, Carlsson LM, Kiess W, Vatin V, Lecoeur C, et al: Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007, 39: 724-726. 10.1038/ng2048.
Hinney A, Nguyen TT, Scherag A, Friedel S, Bronner G, Muller TD, Grallert H, Illig T, Wichmann HE, Rief W, et al: Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS ONE. 2007, 2: e1361-10.1371/journal.pone.0001361.
Zimmermann E, Kring SI, Berentzen TL, Holst C, Pers TH, Hansen T, Pedersen O, Sorensen TI, Jess T: Fatness-associated FTO gene variant increases mortality independent of fatness--in cohorts of Danish men. PLoS ONE. 2009, 4: e4428-10.1371/journal.pone.0004428.
Liu YJ, Liu XG, Wang L, Dina C, Yan H, Liu JF, Levy S, Papasian CJ, Drees BM, Hamilton JJ, et al: Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Hum Mol Genet. 2008, 17: 1803-1813. 10.1093/hmg/ddn072.
Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, Inouye M, Freathy RM, Attwood AP, Beckmann JS, et al: Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008, 40: 768-775. 10.1038/ng.140.
Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A, Styrkarsdottir U, Gretarsdottir S, Thorlacius S, Jonsdottir I, et al: Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet. 2009, 41: 18-24. 10.1038/ng.274.
Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T, et al: Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet. 2004, 74: 572-581. 10.1086/382490.
Stutzmann F, Vatin V, Cauchi S, Morandi A, Jouret B, Landt O, Tounian P, Levy-Marchal C, Buzzetti R, Pinelli L, et al: Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Hum Mol Genet. 2007, 16: 1837-1844. 10.1093/hmg/ddm132.
Herbert A, Gerry NP, McQueen MB, Heid IM, Pfeufer A, Illig T, Wichmann HE, Meitinger T, Hunter D, Hu FB, et al: A common genetic variant is associated with adult and childhood obesity. Science. 2006, 312: 279-283. 10.1126/science.1124779.
Hall DH, Rahman T, Avery PJ, Keavney B: INSIG-2 promoter polymorphism and obesity related phenotypes: association study in 1428 members of 248 families. BMC Med Genet. 2006, 7: 83-10.1186/1471-2350-7-83.
Lyon HN, Emilsson V, Hinney A, Heid IM, Lasky-Su J, Zhu X, Thorleifsson G, Gunnarsdottir S, Walters GB, Thorsteinsdottir U, et al: The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet. 2007, 3: e61-10.1371/journal.pgen.0030061.
Mizuta E, Kokubo Y, Yamanaka I, Miyamoto Y, Okayama A, Yoshimasa Y, Tomoike H, Morisaki H, Morisaki T: Leptin gene and leptin receptor gene polymorphisms are associated with sweet preference and obesity. Hypertens Res. 2008, 31: 1069-1077. 10.1291/hypres.31.1069.
International Obesity Taskforce: About obesity 2005. London, United Kingdom. 2005
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/10/103/prepub